Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Peptides × Clear all

Phase

Status

Completed 13 Unknown 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Carboplatin 125 Cisplatin 124 Drug Therapy 116 Bevacizumab 106 Capecitabine 104 Oxaliplatin 102 Radiotherapy 92 Paclitaxel 90 tislelizumab 88 Gemcitabine 86 Cyclophosphamide 86 pembrolizumab 77 Specimen Handling 74 toripalimab 67 Fluorouracil 63 Magnetic Resonance Spectroscopy 62 Injections 62 sintilimab 56 Surgical Procedures, Operative 56 Docetaxel 56 130-nm albumin-bound paclitaxel 51 Immune Checkpoint Inhibitors 46 anlotinib 45 Biopsy 45 fludarabine 44 Standard of Care 43 Pemetrexed 43 lenvatinib 42 Leucovorin 42 Radiosurgery 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06195618 2025-06-25

TEBICA003 TNBC

Universidad Nacional de Colombia

Phase 1 Not yet recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡